Showing results (181-190 of 209) with videos related to
Sort By:
Pageof 21
Molecular Pharmaceutics|May 24, 2019
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer PatientsJoseph A O'Donoghue, Daniel C Danila, Neeta Pandit-Taskar, et al.The Lancet. Oncology|September 13, 2024
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, et al.Journal of Hematology & Oncology|November 12, 2022
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignanciesKim Kramer, Neeta Pandit-Taskar, Brian H Kushner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
(124)I-huA33 antibody PET of colorectal cancerJorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion TargetingNeeta Pandit-Taskar, Michael A Postow, Matthew D Hellmann, et al.Molecular Cancer Therapeutics|October 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal CarcinomatosisChristopher S Chandler, Meghan M Bell, Sebastian K Chung, et al.The New England Journal of Medicine|February 15, 2013
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancerAlan L Ho, Ravinder K Grewal, Rebecca Leboeuf, et al.Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.British Journal of Haematology|January 14, 2026
Prognostic role of PET/CT volumetric parameters in paediatric Hodgkin lymphoma: A systematic review and expert recommendations from the International SEARCH for CAYAHL GroupS Claire Gowdy, Jamie E Flerlage, Jennifer Seelisch, et al.Clinical Nuclear Medicine|April 30, 2020
Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-upSonia Mahajan, Reiko Nakajima, Mariko Yabe, et al.Pageof 21